Brain and behavior · 2025
Rare Variants Cause Charcot-Marie-Tooth Disease in Malian Families.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yalcouyé Abdoulaye, Cissé Lassana, Diarra Salimata, Diallo Seybou H, Bamba Salia, Yeetong Patra, Maiga Boubacar, Dembélé Kékouta, Coulibaly Dramane, Diallo Salimata, Taméga Abdoulaye, Maiga Alassane Baneye, Ba Hamidou O, Shotelersuk Vorasuk, Fischbeck Kenneth H, Guinto Cheick O, Landouré Guida
Аннотация
INTRODUCTION/AIMS: Charcot-Marie-Tooth disease (CMT), the most common inherited peripheral neuropathy, is clinically and genetically heterogeneous with over 100 genes identified to date. Recently, next-generation sequencing (NGS) has enabled molecular diagnosis in previously unidentified CMT cases. However, less progress has been achieved in sub-Saharan African (SSA) populations. We report rare CMT variants found in four unrelated Malian families.
METHODS: Patients went through a thorough neurological examination and Nerve Conduction Studies (NCS) were performed. DNA was extracted for genetic analysis (CMT gene panel testing and whole-exome/genome sequencing). Putative variants were confirmed with Sanger sequencing and segregation was checked in all available family members. Deleteriousness was checked using several in silico prediction tools and protein modeling.
RESULTS: Nine patients (three males and six females) from four families were enrolled. The mean age at onset and diagnosis were 15 and 22.7 years, respectively (ranges: 3 to 55 years, and 12 to 58 years). Walking difficulty was the first symptom commonly reported. Neurological examination found distal muscle weakness and wasting with sensory loss, reduced tendon reflexes, and skeletal deformities. In addition, some patients presented with ataxic gait associated with incoordination that are not in the forefront of CMT features. NCS was consistent with the axonal pattern in three families. Genetic analysis revealed rare pathogenic variants in BSCL2, SH3TC2, and PEX10, and of unknown significance in BAG3.
DISCUSSION: This study reports rare variants in these CMT genes for the first time in SSA populations, expanding the global epidemiological, clinical, and genetic spectrum of these diseases.
METHODS: Patients went through a thorough neurological examination and Nerve Conduction Studies (NCS) were performed. DNA was extracted for genetic analysis (CMT gene panel testing and whole-exome/genome sequencing). Putative variants were confirmed with Sanger sequencing and segregation was checked in all available family members. Deleteriousness was checked using several in silico prediction tools and protein modeling.
RESULTS: Nine patients (three males and six females) from four families were enrolled. The mean age at onset and diagnosis were 15 and 22.7 years, respectively (ranges: 3 to 55 years, and 12 to 58 years). Walking difficulty was the first symptom commonly reported. Neurological examination found distal muscle weakness and wasting with sensory loss, reduced tendon reflexes, and skeletal deformities. In addition, some patients presented with ataxic gait associated with incoordination that are not in the forefront of CMT features. NCS was consistent with the axonal pattern in three families. Genetic analysis revealed rare pathogenic variants in BSCL2, SH3TC2, and PEX10, and of unknown significance in BAG3.
DISCUSSION: This study reports rare variants in these CMT genes for the first time in SSA populations, expanding the global epidemiological, clinical, and genetic spectrum of these diseases.